Federico Maria Grignolo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Federico Maria Grignolo has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Fea
Eye Clinic, University of Turin, Turin
16 shared publications - Ugo de Sanctis
Department of Surgical Sciences, Eye Clinic, University of Turin, Turin, Italy
15 shared publications - Chiara Maria Eandi
Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Switzerland
11 shared publications - Alessandro Guido Actis
ASL Città di Torino and ASL Torino 3, Turin, Italy -
6 shared publications B. Brogliatti
Eye Clinic, University of Turin
6 shared publications- Camilla Alovisi
Department of Surgical Science, University of Torino, 10126 Torino, Italy
5 shared publications
Latest Publications
- Open Access
- 5 September 2015
- Published by Springer Nature in BMC Ophthalmology
- Vol. 15 (1) , 1-6
Parry Romberg syndrome with a wide range of ocular manifestations: a case report
Parry-Romberg syndrome (PRS) is a rare disorder characterized by unilateral facial atrophy affecting the skin, subcutaneous tissue, muscles, and sometimes extending to the osteocartilaginous structures. Ocular involvement is relatively rare. We present a case of a 23-year-old female caucasian patient with Parry Romberg syndrome and extensive ocular involvement: enophthalmos, uveitis, iris atrophy. Ultrasound biomicroscopy (UBM) demonstrated hypotrophy of the ciliary body. The ciliary body atrophy has been previously reported just once and can be an explanation for the hypotony, frequently present in these patients. Parry Romberg syndrome is a rare multidisciplinary disease. Our case presents a full spectrum of ocular manifestations. The pathogenesis of hypotonia is discussed.
- 5 September 2015
- Published by Springer Nature in BMC Ophthalmology
- Vol. 15 (1) , 1-6
Open AccessParry Romberg syndrome with a wide range of ocular manifestations: a case report
Parry-Romberg syndrome (PRS) is a rare disorder characterized by unilateral facial atrophy affecting the skin, subcutaneous tissue, muscles, and sometimes extending to the osteocartilaginous structures. Ocular involvement is relatively rare. We present a case of a 23-year-old female caucasian patient with Parry Romberg syndrome and extensive ocular involvement: enophthalmos, uveitis, iris atrophy. Ultrasound biomicroscopy (UBM) demonstrated hypotrophy of the ciliary body. The ciliary body atrophy has been previously reported just once and can be an explanation for the hypotony, frequently present in these patients. Parry Romberg syndrome is a rare multidisciplinary disease. Our case presents a full spectrum of ocular manifestations. The pathogenesis of hypotonia is discussed.
- 22 July 2015
- Published by Taylor & Francis in Current Eye Research
- Vol. 41 (5) , 1-9
Diagnostic Power of Macular Retinal Thickness Analysis and Structure-Function Relationship in Glaucoma Diagnosis Using SPECTRALIS OCT
To evaluate the diagnostic power of the Posterior Pole Asymmetry Analysis (PPAA) from the SPECTRALIS OCT in glaucoma diagnosis and to define the correlation between the visual field sensitivity (VFS) and macular retinal thickness (MRT).
- 22 July 2015
- Published by Taylor & Francis in Current Eye Research
- Vol. 41 (5) , 1-9
Diagnostic Power of Macular Retinal Thickness Analysis and Structure-Function Relationship in Glaucoma Diagnosis Using SPECTRALIS OCT
To evaluate the diagnostic power of the Posterior Pole Asymmetry Analysis (PPAA) from the SPECTRALIS OCT in glaucoma diagnosis and to define the correlation between the visual field sensitivity (VFS) and macular retinal thickness (MRT).
- Open Access
- 1 April 2015
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 9, 563-74
Recent developments in the management of dry age-related macular degeneration
Dry age-related macular degeneration (AMD), also called geographic atrophy, is characterized by the atrophy of outer retinal layers and retinal pigment epithelium (RPE) cells. Dry AMD accounts for 80% of all intermediate and advanced forms of the disease. Although vision loss is mainly due to the neovascular form (75%), dry AMD remains a challenge for ophthalmologists because of the lack of effective therapies. Actual management consists of lifestyle modification, vitamin supplements, and supportive measures in the advanced stages. The Age-Related Eye Disease Study demonstrated a statistically significant protective effect of dietary supplementation of antioxidants (vitamin C, vitamin E, beta-carotene, zinc, and copper) on dry AMD progression rate. It was also stated that the consumption of omega-3 polyunsaturated fatty acids, such as docosahexaenoic acid and eicosapentaenoic acid, has protective effects. Other antioxidants, vitamins, and minerals (such as crocetin, curcumin, and vitamins B9, B12, and B6) are under evaluation, but the results are still uncertain. New strategies aim to 1) reduce or block drusen formation, 2) reduce or eliminate inflammation, 3) lower the accumulation of toxic by-products from the visual cycle, 4) reduce or eliminate retinal oxidative stress, 5) improve choroidal perfusion, 6) replace/repair or regenerate lost RPE cells and photoreceptors with stem cell therapy, and 7) develop a target gene therapy.
- 1 April 2015
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 9, 563-74
Open AccessRecent developments in the management of dry age-related macular degeneration
Dry age-related macular degeneration (AMD), also called geographic atrophy, is characterized by the atrophy of outer retinal layers and retinal pigment epithelium (RPE) cells. Dry AMD accounts for 80% of all intermediate and advanced forms of the disease. Although vision loss is mainly due to the neovascular form (75%), dry AMD remains a challenge for ophthalmologists because of the lack of effective therapies. Actual management consists of lifestyle modification, vitamin supplements, and supportive measures in the advanced stages. The Age-Related Eye Disease Study demonstrated a statistically significant protective effect of dietary supplementation of antioxidants (vitamin C, vitamin E, beta-carotene, zinc, and copper) on dry AMD progression rate. It was also stated that the consumption of omega-3 polyunsaturated fatty acids, such as docosahexaenoic acid and eicosapentaenoic acid, has protective effects. Other antioxidants, vitamins, and minerals (such as crocetin, curcumin, and vitamins B9, B12, and B6) are under evaluation, but the results are still uncertain. New strategies aim to 1) reduce or block drusen formation, 2) reduce or eliminate inflammation, 3) lower the accumulation of toxic by-products from the visual cycle, 4) reduce or eliminate retinal oxidative stress, 5) improve choroidal perfusion, 6) replace/repair or regenerate lost RPE cells and photoreceptors with stem cell therapy, and 7) develop a target gene therapy.
- 1 April 2015
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 159 (4) , 652-658.e1
Correlation Between Fundus Autofluorescence and Central Visual Function in Chronic Central Serous Chorioretinopathy
- 1 April 2015
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 159 (4) , 652-658.e1
Correlation Between Fundus Autofluorescence and Central Visual Function in Chronic Central Serous Chorioretinopathy
- 1 January 2015
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 159 (1) , 205-206
Reply
- 1 January 2015
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 159 (1) , 205-206
Reply
- Open Access
- 3 October 2014
- Published by Bentham Science Publishers Ltd. in The Open Ophthalmology Journal
- Vol. 8 (1) , 51-59
In Vivo Confocal Microscopic Evaluation of Corneal Langerhans Cells in Dry Eye Patients§
Purpose.: To assess inflammatory involvement of cornea in dry eye by means of confocal microscopy, evaluating the presence and distribution of Langherans cells (LCs).Methods: 98 eyes of 49 subjects were enrolled: 18 subjects affected by Sjögren Syndrome Dry Eye (SSDE), 17 with Non-Sjögren Syndrome Dry Eye (NSSDE), 14 healthy volunteeers. Dry eye symptoms, tear film, ocular surface damage and corneal confocal microscopy were analized.Results: A significant increase of LCs density was observed at sub-basal nerve plexus (SSDE = 79 cells/mm2andNDE = 22 cells/mm2;p= 0,0031) and sub-epithelial nerve plexus (SSDE = 38 cells/mm2and NDE = 3 cells/mm2;p= 0,0169) in central cornea of SSDE group. An increased number of LCs from the center to the periphery of the cornea was observed, significant only in healthy volunteers group. In dry eye patients there was an increase in LCs density in both peripheral and central cornea with a significant difference between NDE (14,66 cells/mm2) and SSDE (56,66 cells/mm2) only in central cornea (p= 0,0028). In SSDE group, mean density of LCs in central cornea results also superior to NSSDE group (29,33 cells/mm2).There was no correlation between LCs density and dry eye symptoms, tear film deficiency and ocular surface damage.Conclusion: This study demonstrates the activation of an inflammatory and immunological reaction in cornea of NSSDE and SSDE patients. Confocal microscopy can be an important diagnostic tool in evaluation and follow-up of dry eye disease.
- 3 October 2014
- Published by Bentham Science Publishers Ltd. in The Open Ophthalmology Journal
- Vol. 8 (1) , 51-59
Open AccessIn Vivo Confocal Microscopic Evaluation of Corneal Langerhans Cells in Dry Eye Patients§
Purpose.: To assess inflammatory involvement of cornea in dry eye by means of confocal microscopy, evaluating the presence and distribution of Langherans cells (LCs).Methods: 98 eyes of 49 subjects were enrolled: 18 subjects affected by Sjögren Syndrome Dry Eye (SSDE), 17 with Non-Sjögren Syndrome Dry Eye (NSSDE), 14 healthy volunteeers. Dry eye symptoms, tear film, ocular surface damage and corneal confocal microscopy were analized.Results: A significant increase of LCs density was observed at sub-basal nerve plexus (SSDE = 79 cells/mm2andNDE = 22 cells/mm2;p= 0,0031) and sub-epithelial nerve plexus (SSDE = 38 cells/mm2and NDE = 3 cells/mm2;p= 0,0169) in central cornea of SSDE group. An increased number of LCs from the center to the periphery of the cornea was observed, significant only in healthy volunteers group. In dry eye patients there was an increase in LCs density in both peripheral and central cornea with a significant difference between NDE (14,66 cells/mm2) and SSDE (56,66 cells/mm2) only in central cornea (p= 0,0028). In SSDE group, mean density of LCs in central cornea results also superior to NSSDE group (29,33 cells/mm2).There was no correlation between LCs density and dry eye symptoms, tear film deficiency and ocular surface damage.Conclusion: This study demonstrates the activation of an inflammatory and immunological reaction in cornea of NSSDE and SSDE patients. Confocal microscopy can be an important diagnostic tool in evaluation and follow-up of dry eye disease.
- 1 October 2014
- Published by Wiley in Optometry and Vision Science
- Vol. 91 (10) , 1251-1258
Total Spherical Aberration of the Cornea in Patients with Cataract
Purpose: To investigate the distribution of corneal spherical aberration in patients with cataract using the Pentacam HR. Methods: Consecutive cataract patients were examined using the Pentacam HR high‐resolution rotating Scheimpflug camera (Oculus, Wetzlar, Germany). In one eye of each patient, the root‐mean‐square (RMS) of anterior, posterior, and total corneal spherical aberration Z 4 0 was calculated by ray‐tracing on an area of 6 mm diameter. The Pearson correlation coefficient ( r ) was used to assess correlations between Z 4 0 RMS values and age/total corneal refractive power. The χ 2 test was used to compare the proportion of eyes qualifying for spherically neutral or negatively aspheric (−0.17 and −0.27 μm) intraocular lenses (IOLs) by targeted level of residual spherical aberration. Results: Fifty‐seven men and 92 women were included (mean [±SD] age, 71.73 [±9.12] years). The RMS mean (±SD) values of Z 4 0 were +0.353 (±0.132) μm, −0.121 (±0.034) μm, and +0.328 (±0.132) μm, respectively, for the anterior, posterior, and total cornea. The anterior, posterior, and total Z 4 0 were on average significantly higher (p < 0.001) in women than in men. In both sexes, statistically significant (p < 0.05) age‐related changes were found for the anterior and total Z 4 0 but not for the posterior Z 4 0 (p > 0.05). The total Z 4 0 and total corneal refractive power were significantly correlated in men (p = 0.01) but not in women (p = 0.14). For postoperative targets of 0 ± 0.05/+0.10 ± 0.05 μm residual Z 4 0 , the proportion of eyes that would have qualified for implantation of negatively aspheric IOLs with −0.17 and with −0.27 μm was similar (61.1 and 56.3%, respectively; p = 0.09); significantly fewer eyes (6.7%) would have qualified for implantation of neutrally aspheric IOLs (p > 0.05). Conclusions: Total corneal Z 4 0 measured by Pentacam HR might be higher than that reported in previous studies. In most patients, the implantation of commercially available negatively aspheric IOLs would partially compensate for the positive total corneal Z 4 0 .
- 1 October 2014
- Published by Wiley in Optometry and Vision Science
- Vol. 91 (10) , 1251-1258
Total Spherical Aberration of the Cornea in Patients with Cataract
Purpose: To investigate the distribution of corneal spherical aberration in patients with cataract using the Pentacam HR. Methods: Consecutive cataract patients were examined using the Pentacam HR high‐resolution rotating Scheimpflug camera (Oculus, Wetzlar, Germany). In one eye of each patient, the root‐mean‐square (RMS) of anterior, posterior, and total corneal spherical aberration Z 4 0 was calculated by ray‐tracing on an area of 6 mm diameter. The Pearson correlation coefficient ( r ) was used to assess correlations between Z 4 0 RMS values and age/total corneal refractive power. The χ 2 test was used to compare the proportion of eyes qualifying for spherically neutral or negatively aspheric (−0.17 and −0.27 μm) intraocular lenses (IOLs) by targeted level of residual spherical aberration. Results: Fifty‐seven men and 92 women were included (mean [±SD] age, 71.73 [±9.12] years). The RMS mean (±SD) values of Z 4 0 were +0.353 (±0.132) μm, −0.121 (±0.034) μm, and +0.328 (±0.132) μm, respectively, for the anterior, posterior, and total cornea. The anterior, posterior, and total Z 4 0 were on average significantly higher (p < 0.001) in women than in men. In both sexes, statistically significant (p < 0.05) age‐related changes were found for the anterior and total Z 4 0 but not for the posterior Z 4 0 (p > 0.05). The total Z 4 0 and total corneal refractive power were significantly correlated in men (p = 0.01) but not in women (p = 0.14). For postoperative targets of 0 ± 0.05/+0.10 ± 0.05 μm residual Z 4 0 , the proportion of eyes that would have qualified for implantation of negatively aspheric IOLs with −0.17 and with −0.27 μm was similar (61.1 and 56.3%, respectively; p = 0.09); significantly fewer eyes (6.7%) would have qualified for implantation of neutrally aspheric IOLs (p > 0.05). Conclusions: Total corneal Z 4 0 measured by Pentacam HR might be higher than that reported in previous studies. In most patients, the implantation of commercially available negatively aspheric IOLs would partially compensate for the positive total corneal Z 4 0 .
- 1 May 2014
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 157 (5) , 1033-1037.e2
Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
- 1 May 2014
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 157 (5) , 1033-1037.e2
Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
- Open Access
- 1 April 2014
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 8, 681-3
Terson syndrome and leukemia: a case report
Terson syndrome and leukemia: a case report Umberto Lorenzi, Elisa Buschini, Antonio Fea, Federica Machetta, Federico Maria GrignoloOphthalmic Section, Department of Clinical Pathophysiology, University of Turin, Turin, Italy Abstarct: Terson syndrome is defined as intraocular hemorrhage associated with intracranial bleeding. This syndrome can occur in the event of intracranial hemorrhage or elevated intracranial pressure. To our knowledge, it has never been associated with chronic myeloid leukemia. A 45-year-old woman suffering from chronic myeloid leukemia was referred to our clinic with Terson syndrome after intracranial bleeding. We followed this patient for a year, performing visual acuity assessment, fundus examination, color retinography, and A-scan and B-scan ultrasonography. At presentation, her best-corrected visual acuity on the right was 20/63 and on the left was 20/320. In the right eye, retinoscopy showed blurring of the optic margins surrounded by retinal and preretinal hemorrhages, preretinal fibrosis of the optic disc along the vascular arcades, and perivascular retinal infiltrates. In the left eye, the optic disc was surrounded by retinal and preretinal hemorrhages, and massive fibrosis with hard exudates and severe preretinal hemorrhage were observed at the posterior pole. Roth spots and many circular hemorrhages were noted at the periphery of the retina. A-scan and B-scan ultrasonography did not show intraocular leukemic infiltration. The clinical picture remained stable over the following 12 months. In this patient, we observed the ophthalmoscopic features of chronic myeloid leukemia, but also coexistence of features typical of Terson syndrome. To our knowledge, no similar cases have been reported previously.Keywords: retinal disease, chronic myeloid leukemia, eye hemorrhage, intracranial hemorrhage
- 1 April 2014
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 8, 681-3
Open AccessTerson syndrome and leukemia: a case report
Terson syndrome and leukemia: a case report Umberto Lorenzi, Elisa Buschini, Antonio Fea, Federica Machetta, Federico Maria GrignoloOphthalmic Section, Department of Clinical Pathophysiology, University of Turin, Turin, Italy Abstarct: Terson syndrome is defined as intraocular hemorrhage associated with intracranial bleeding. This syndrome can occur in the event of intracranial hemorrhage or elevated intracranial pressure. To our knowledge, it has never been associated with chronic myeloid leukemia. A 45-year-old woman suffering from chronic myeloid leukemia was referred to our clinic with Terson syndrome after intracranial bleeding. We followed this patient for a year, performing visual acuity assessment, fundus examination, color retinography, and A-scan and B-scan ultrasonography. At presentation, her best-corrected visual acuity on the right was 20/63 and on the left was 20/320. In the right eye, retinoscopy showed blurring of the optic margins surrounded by retinal and preretinal hemorrhages, preretinal fibrosis of the optic disc along the vascular arcades, and perivascular retinal infiltrates. In the left eye, the optic disc was surrounded by retinal and preretinal hemorrhages, and massive fibrosis with hard exudates and severe preretinal hemorrhage were observed at the posterior pole. Roth spots and many circular hemorrhages were noted at the periphery of the retina. A-scan and B-scan ultrasonography did not show intraocular leukemic infiltration. The clinical picture remained stable over the following 12 months. In this patient, we observed the ophthalmoscopic features of chronic myeloid leukemia, but also coexistence of features typical of Terson syndrome. To our knowledge, no similar cases have been reported previously.Keywords: retinal disease, chronic myeloid leukemia, eye hemorrhage, intracranial hemorrhage
- 24 February 2014
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 24 (5) , 814-817
Homozygous c.1937+1G>A Splice-Site Variant of the ABCA4 gene is Associated with Stargardt Disease
Purpose: To report the phenotype of homozygous ABCA4 c.1937+1G>A splice-site variant associated with Stargardt disease. Methods: Two siblings, a 10-year-old boy and a 32-year-old woman, born from consanguineous parents, presented with central vision loss and macular pigmentary atrophic changes suggestive of Stargardt disease. After genetic counselling, ABCA4 gene analysis was performed. Results: The 2 siblings affected were shown to be homozygous for the c.1937+1G>A splice junction variant of the ABCA4 gene. Both parents were heterozygous for the same mutation; they were asymptomatic and the fundus examination revealed a normal appearance. Conclusions: Thus far, ABCA4 c.1937+1G>A splice-site variant was shown to cause retinitis pigmentosa when in hemizygosity and Stargardt disease when present on one allele. In this family two sibs homozygous for the ABCA4 c.1937+1G>A splice-site variant have a less severe phenotype of Stargardt disease. This observation provides useful information for the diagnosis and counseling of patients with this ABCA4 variant.
- 24 February 2014
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 24 (5) , 814-817
Homozygous c.1937+1G>A Splice-Site Variant of the ABCA4 gene is Associated with Stargardt Disease
Purpose: To report the phenotype of homozygous ABCA4 c.1937+1G>A splice-site variant associated with Stargardt disease. Methods: Two siblings, a 10-year-old boy and a 32-year-old woman, born from consanguineous parents, presented with central vision loss and macular pigmentary atrophic changes suggestive of Stargardt disease. After genetic counselling, ABCA4 gene analysis was performed. Results: The 2 siblings affected were shown to be homozygous for the c.1937+1G>A splice junction variant of the ABCA4 gene. Both parents were heterozygous for the same mutation; they were asymptomatic and the fundus examination revealed a normal appearance. Conclusions: Thus far, ABCA4 c.1937+1G>A splice-site variant was shown to cause retinitis pigmentosa when in hemizygosity and Stargardt disease when present on one allele. In this family two sibs homozygous for the ABCA4 c.1937+1G>A splice-site variant have a less severe phenotype of Stargardt disease. This observation provides useful information for the diagnosis and counseling of patients with this ABCA4 variant.